Skip to main content

Advertisement

SpringerLink
Log in

Recognizing CADASIL: a Secondary Cause of Migraine with Aura

  • Uncommon and/or Unusual Headaches and Syndromes (J Ailani, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is an important disease to consider in the differential diagnosis of migraine with aura. This review examines current literature regarding migraine in CADASIL, as well as diagnostic and treatment modalities.

Recent Findings

Recent studies have shown that smoking is a modifiable risk factor for progression of CADASIL (Chabriat et al. in Stroke 47:4–11, 2015). Specific imaging changes and findings on clinical exam can predict disease progression. However, migraine symptoms often precede MRI changes (Guey et al. in Cephalalgia 36:1038–47, 2015). A recent paper on migraine treatment in CADASIL reevaluates the prevailing belief that vasoconstrictive abortive medications are contraindicated in these patients (Tan and Markus in PLoS ONE 11:e0157613, 2016).

Summary

CADASIL is an autosomal dominantly inherited vasculopathy causing ischemic pathology in younger individuals due to a mutation in the NOTCH3 gene. The mutation results in impaired arterial contractility due to accumulation of granular osmiophilic extracellular material (GOM) in vascular smooth muscle cells (VSMCs). Clinical manifestations include migraine with and without aura, cognitive decline, ischemic events, and mood disorders. The presenting symptom is often migraine with aura. Characteristic MRI changes are often present. Genetic screening is available to confirm NOTCH3 mutation and pathognomic changes are often seen in skin biopsy. Treatment of migraine is similar to the general population, but with some notable and specific differences. Further studies in CADASIL, other small vessel arteriopathies, and migraine may help us understand more about the pathophysiology of these conditions and help with treatment development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser M. CADASIL. Lancet Neurol. 2009;8:643–53. Comprehensive review article from 2009 discussing pathophysiology, symptoms, diagnosis, treatment and progression.

    Article  PubMed  Google Scholar 

  2. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707–10.

    Article  CAS  PubMed  Google Scholar 

  3. • Tikka S, Baumann M, Siitonen M, et al. CADASIL and CARASIL. Brain Pathol. 2014;24:525–44. Recent article on the genetics and pathology of CADASIL and CARASIL.

    Article  CAS  PubMed  Google Scholar 

  4. Kalimo H, Ruchoux M, Viitanen M, Kalaria R. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol. 2002;12:371–84.

    Article  CAS  PubMed  Google Scholar 

  5. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Investig. 2000;105:597–605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Chabriat H, Vahedi K, Bousser M, et al. Clinical spectrum of CADASIL: a study of 7 families. Lancet. 1995;346:934–9.

    Article  CAS  PubMed  Google Scholar 

  7. Ruchoux M, Maurage C. CADASIL. J Neuropathol Exp Neurol. 1997;56:947–64.

    Article  CAS  PubMed  Google Scholar 

  8. Dichgans M, Mayer M, Uttner I, Brüning R, Müller-Höcker J, Rungger G, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44:731–9.

    Article  CAS  PubMed  Google Scholar 

  9. Liem M, Oberstein S, van der Grond J, Ferrari M, Haan J. CADASIL and migraine: a narrative review. Cephalalgia. 2010;30:1284–9.

    Article  PubMed  Google Scholar 

  10. • Guey S, Mawet J, Herve D, Duering M, Godin O, Jouvent E, et al. Prevalence and characteristics of migraine in CADASIL. Cephalalgia. 2015;36:1038–47. Prospective cohort of 378 CADASIL patients evaluating migraine symptoms and possible correlates with symptoms, severity and MRI findings.

    Article  Google Scholar 

  11. Gunda B, Herve D, Godin O, et al. Effects of gender on the phenotype of CADASIL. Stroke. 2011;43:137–41.

    Article  PubMed  Google Scholar 

  12. •• Tan R, Markus H. CADASIL: migraine, encephalopathy, stroke and their inter-relationships. PLoS ONE. 2016;11:e0157613. Recently completed prospective study with 300 symptomatic CADASIL patients examining migraine patterns, treatment responses and associations between migraine, stroke and encephalopathy. First article to document use of vasoconstrictive treatment with triptans and ergots in CADASIL patients.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Adib-Samii P, Brice G, Martin R, Markus H. Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke. 2010;41:630–4.

    Article  PubMed  Google Scholar 

  14. Vahedi K, Chabriat H, Levy C, Joutel A, Tournier-Lasserve E, Bousser M. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol. 2004. doi:10.1001/archneur.61.8.1237.

    PubMed  Google Scholar 

  15. • Zhu S, Nahas S. CADASIL: imaging characteristics and clinical correlation. Curr Pain Headache Rep. 2016. doi:10.1007/s11916-016-0584-6. Recent article reviewing imaging findings in CADASIL and correlation with clinical symptoms.

    Google Scholar 

  16. Desmond D, Moroney J, Lynch T, Chan S, Chin S, Mohr J. The natural history of CADASIL : a pooled analysis of previously published cases. Stroke. 1999;30:1230–3.

    Article  CAS  PubMed  Google Scholar 

  17. Liem M, Lesnik Oberstein S, Haan J, van der Neut I, van den Boom R, Ferrari M, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: progression of MR abnormalities in prospective 7-year Follow-up Study. Radiology. 2008;249:964–71.

    Article  PubMed  Google Scholar 

  18. Chabriat H, Mrissa R, Levy C, Vahedi K, Taillia H, Iba-Zizen M, et al. Brain stem MRI signal abnormalities in CADASIL. Stroke. 1999;30:457–9.

    Article  CAS  PubMed  Google Scholar 

  19. Viswanathan A. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain. 2006;129:2375–83.

    Article  PubMed  Google Scholar 

  20. Peters N, Holtmannspotter M, Opherk C, Gschwendtner A, Herzog J, Samann P, et al. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology. 2006;66:1517–22.

    Article  CAS  PubMed  Google Scholar 

  21. Peters N, Opherk C, Bergmann T, Castro M, Herzog J, Dichgans M. Spectrum of mutations in biopsy-proven CADASIL. Arch Neurol. 2005;62:1091.

    Article  PubMed  Google Scholar 

  22. •• Chabriat H, Hervé D, Duering M, et al. Predictors of clinical worsening in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 2015;47:4–11. Prospective cohort study of 290 CADASIL patients evaluating for demographic, clinical, and MRI predictors of stroke, dementia, clinical worsening and death. Underlines importance of imaging and exam in predicting disease progression and showed that smoking is a modifiable risk factor for progression.

    Article  PubMed  Google Scholar 

  23. Forteza A, Brozman B, Rabinstein A, Romano J, Bradley W. Acetazolamide for the treatment of migraine with aura in CADASIL. Neurology. 2001;57:2144–5.

    Article  CAS  PubMed  Google Scholar 

  24. • Donnini I, Nannucci S, Valenti R, Pescini F, Bianchi S, Inzitari D, et al. Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. J Headache Pain. 2012;13:299–302. Retrospective study looking at 7 patients treated with acetazolamide for migraine prophylaxis and their responses.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. • Ferrari M, Klever R, Terwindt G, Ayata C, van den Maagdenberg A. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 2015;14:65–80. Review article summarizing recent findings in mouse models and possible connections in humans in regards to migraine and aura pathophysiology.

    Article  CAS  PubMed  Google Scholar 

  26. Brennan K, Beltran-Parrazal L, Lopez-Valdes H, Theriot J, Toga A, Charles A. Distinct vascular conduction with cortical spreading depression. J Neurophysiol. 2007;97:4143–51.

    Article  PubMed  Google Scholar 

  27. Hadjikhani N, Sanchez del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci. 2001;98:4687–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Haffner C, Vinters H. CADASIL, CARASIL, CARASAL. Neurology. 2016;87:1752–3.

    Article  PubMed  Google Scholar 

  29. Chabriat H, Tournier-Lasserve E, Vahedi K, et al. Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus. Neurology. 1995;45:1086–91.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, MedStar Georgetown University Hospital, 3800 Reservoir Road NW, 7-PHC, Washington, DC, 20007, USA

    John Glenn Burkett & Carrie Dougherty

Authors
  1. John Glenn Burkett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carrie Dougherty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carrie Dougherty.

Ethics declarations

Conflict of Interest

Dr. John Glenn Burkett and Dr. Carrie Dougherty each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Uncommon and/or Unusual Headaches and Syndromes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burkett, J.G., Dougherty, C. Recognizing CADASIL: a Secondary Cause of Migraine with Aura. Curr Pain Headache Rep 21, 21 (2017). https://doi.org/10.1007/s11916-017-0621-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-017-0621-0

Keywords

Search

Navigation